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Purpose: To investigate the structure–function relationship in eyes with drusen with
mesopic and scotopic microperimetry.
Methods: We analyzed structural and functional data from 43 eyes with drusen.
Functional data were acquired with mesopic and scotopic two-color (red and cyan)
microperimetry. Normative values were calculated using data from 56 healthy eyes.
Structural measurements were green autofluorescence and dense macular optical
coherence tomography scans. The latter were used to calculate the retinal pigment
epithelium elevation (RPE-E) and the photoreceptor reflectivity ratio (PRR). The point-
wise structure–function relationshipwasmeasuredwith linearmixedmodels having the
log-transformed structural parameters as predictors and the sensitivity loss (SL, devia-
tion from normal) as the response variable.
Results: In the univariable analysis, the structural predictors were all significantly
correlated (P < 0.05) with the SL in the mesopic and scotopic tests. In a multivari-
able model, mesopic microperimetry yielded the best structure–function relation-
ship. All predictors were significant (P < 0.05), but the predictive power was weak
(bestR2 =0.09). The relationshipwas improvedwhenanalyzing locationswith abnormal
RPE-E (best R2 = 0.18).
Conclusions: Mesopic microperimetry shows better structure–function relationship
compared to scotopic microperimetry; the relationship is weak, likely due to the early
functional damage and the small number of tested locations affected by drusen. The
relationship is stronger when locations with drusen are isolated for the mesopic and
scotopic cyan test.
Translational Relevance: These results could be useful to devise integrated structure–
function methods to detect disease progression in intermediate age-related macular
degeneration.
Introduction
Macular damage and its progression can be
assessed with functional and structural tests in patients
with intermediate age-related macular degeneration
(iAMD). Two commonly used technologies for struc-
tural evaluation are spectral domain optical coher-
ence tomography (SD-OCT) and fundus autofluores-
cence (FAF).1 Compared to color fundus photogra-
phy, they provide data that are more easily quanti-
fied, such as thickness and reflectivity of different
retinal layers with SD-OCT and fluorescent properties
of lipofuscin with FAF.1 In iAMD, SD-OCT has been
employed to identify location, characteristics, and size
of macular drusen, a predominant structural feature in
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these patients,2,3 and both OCT and FAF have been
used to aid detection of progression to geographic
atrophy (GA).4
Structural changes define the disease, but visual
function is more important to the patient. Moreover,
functional testing is also of paramount importance
in detecting the progression of damage.5–8 Several
functional tests are available, including best-corrected
visual acuity (BCVA), dark adaptometry, reading
speed, andmicroperimetry.7,9–11 The latter is a perimet-
ric test that employs continuous infrared fundus
imaging to track and compensate for eye movements
during the test.12–14 Originally introduced to allow
perimetry in patients with advanced macular damage
and poor fixation, it is presently a cornerstone in
characterization of functional loss in AMD due to
its better correlation with anatomic features compared
to traditional perimetry and global functional metrics
such as BCVA.13–16 Moreover, microperimetry is an
approved functional outcome for clinical trials by the
US Food and Drug Administration.17 Microperimetry
has the potential to highlight differences in function
in iAMD when performed in mesopic and scotopic
conditions,15,18–20 since the visual performance of these
patients is affected by lighting conditions.21–23
There exists interest in developing outcome
measures with sufficient precision to assess change
in iAMD for clinical trials, as interventions are more
likely to be effective if given early in the evolution of
AMD before the onset of GA, which represents an
advanced stage of atrophy and permanent structural
damage. Moreover, clinical trials with efficient end
points are a critical step for speeding up the process of
proving effective treatments for patient benefit.24 It is
not sufficient to test structural and functional endpoint
categories in isolation. Detecting progression might
be limited by the imprecision in both the functional
and structural measurements. Therefore, a natural
step forward is to combine these two different sources
of information. The starting point of this work is to
examine the level of association between structural and
functional measures in iAMD. Since microperimetry
provides accurate anatomic landmarks, a more precise
mapping of perimetric sensitivities onto the structural
maps is possible.
The localized (pointwise) relationship between
structure and function in iAMD has been studied
before, in both mesopic16,20 and scotopic20 condi-
tions. However, the only direct comparison of the
structure–function relationship between mesopic and
scotopic microperimetry has been performed with the
Nidek MP-1S microperimeter (Nidek Technologies,
Padua, Italy), which uses achromatic stimuli for both
the mesopic and scotopic test.20 In contrast, a recent
version of the MAIA microperimeter (CenterVue,
Padua, Italy), the scotopic MAIA (S-MAIA), is able
to stimulate the retina with two different wavelengths,
potentially targeting different pathways in the dark
adapted retina.15,25 Comparing the structure–function
relationship in these different testing conditions could
identify candidate paradigms to characterize progres-
sion in iAMD, and this is the main idea of our work.
We aim to test the strength of the relationship
between structural features of drusen with microperi-
metric sensitivities at individual test locations acquired
with achromatic stimuli inmesopic conditions andwith
two wavelength stimuli in scotopic conditions.
Methods
Data Set
We used data prospectively collected in the North-
ern Ireland Sensory Aging 2 (NISA-2) study (https://
clinicaltrials.gov/ct2/show/NCT02788695), consisting
of a subset of participants in the Northern Ireland
Cohort for the Longitudinal Study of Ageing
(NICOLA) asdas study (https://www.qub.ac.uk/sites/
NICOLA/), which is an ongoing population-based
study conducted at Queen’s University, Belfast. All
data were collected after acquiring written informed
consent from the participants, and the study adhered
to the tenets of the Declaration of Helsinki. The objec-
tive of NISA-2 was to obtain imaging and functional
data from an aging population (N = 402). For the
current study, we extracted the data pertaining to a
subcohort of participants without diabetes mellitus
who had SD-OCT macular scans, dual-wavelength
FAF images, and scotopic and mesopic microperime-
try. Scotopic perimetry was only available during the
latter part of data collection, and the earliest versions
of the commercial device were used. Only one eye per
patient was tested for microperimetry in this study.
Prior to imaging and microperimetry, all patients
were pharmacologically dilated with tropicamide 1%.
The study eye was chosen as the one with worse
BCVA. If both eyes were eligible, the right eye was
chosen. History of amblyopia precluded the selection
of the amblyopic eye. Two independent graders first
evaluated all eyes using color fundus pictures. These
were classified into different AMD groups accord-
ing to the Beckman classification,3 reported in the
Appendix. Only people with advanced AMD (group
4 in our classification) were excluded based on this
classification. The same graders then evaluated the
SD-OCT images to identify morphologic abnormal-
ities of the outer retina. We used this classification
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Table 1. Demographics of the Analyzed Sample
Median [Interquartile Range]
Characteristic Healthy (n = 56) Drusen (n = 43)
Age (y) 62 [58, 67] 72 [64, 78]
Male/female, No. 26/30 22/21
BCVA (letters) 88 [84, 90] 84 [79, 87]
Mean sensitivity (dB) Mesopic 25.48 [24.58, 26.20] 24.32 [22.77, 25.25]
Scotopic, red 13.23 [12.24, 14.03] 12.53 [10.40 14.07]
Scotopic, cyan 11.74 [10.50, 12.42] 10.43 [9.12 12.10]
Spherical equivalent (diopters) 0.5 [−1.12, +1.50] 0.5 [0, +1.62]
to detect eyes with any macular drusen and healthy
controls. Of course, drusen do not necessarily identify
people with iAMD. However, 33 of 43 (77%) people
with drusen identified on OCT scans were classified
as having iAMD with the Beckman classification.
Eyes with reticular pseudodrusen were excluded. Eyes
with pseudodrusen were identified using color fundus
pictures, infrared scanning laser ophthalmoscopy
(SLO), or FAF, regardless of the SD-OCT appearance.
All images were further screened by an ophthalmolo-
gist (GM) to identify and exclude eyes with diseases
of the inner retina, looking for localized or diffused
thinning of the retinal nerve fiber layer or the ganglion
cell layer. Eyes with poor-quality OCT scans or for
which FAF and both mesopic and scotopic tests were
not available were also excluded. Poor-quality scans
were those in which the retinal thickness was not fully
contained within the image or graders were not able
to correctly identify all retinal layers. This led to the
final selection of 56 visually healthy controls and 43
people with drusen. Demographic characteristics of
the sample are reported in Table 1. Four eyes with
drusen had an intraocular lens implant. Lens opacity
in the remaining eyes was graded with a Pentacam
Scheimpflug System (Oculus, Wetzlar, Germany) using
the Pentacam Nucleus Staging (PNS) classification.26
Twenty-three eyes with drusen and 38 healthy eyes had
a PNS = 0. The remaining eyes had a PNS = 1, except
for one eye with drusen with a PNS = 2. No posterior
capsular opacity was reported.
SD-OCT Imaging
The SD-OCT data used in this analysis were
composed of macular scans covering the central 30
× 30 degrees with 61 B-scans (Automatic Real-time
Tracking (ART) set to nine-scan average). All data were
collected with the Spectralis HRA–SD-OCT device
(Heidelberg Engineering, Heidelberg, Germany). The
device uses infrared SLO to track eye movements
during the acquisition of the image. As a result, all
OCT maps can be overlaid with the infrared fundus
picture. The image acquisition was performed with a
central fixation target and focusing on the retina. The
average quality index of the OCT scans was 32.01 ±
2.82 dB (mean ± SD) for patients with drusen and
32.68 ± 2.28 dB for the healthy cohort.
FAF Imaging
The Spectralis HRA–SD-OCT equipped with a
macular pigment optical density (MPOD) module is
able to acquire dual-wavelength autofluorescence (AF)
data. For the acquisition, fluorescence is generated by
exciting the retina with two different wavelengths, blue
autofluorescence (488 nm) and green autofluorescence
(GAF, 518 nm). They both excite lipofuscin, the promi-
nent naturally occurring fluorophore in the retina,
mainly localized at the level of the retinal pigment
epithelium (RPE). However, the blue light is absorbed
muchmore than the green light by themacular pigment
(MP), concentrated at the fovea in the inner layers.
The fluorescent signal was recorded at a wavelength
above 530 nm, filtering out the excitation wavelengths,
after bleaching the retina for 30 seconds to minimize
rhodopsin absorption. The combination of the signal
from the two wavelength provides an optical quantifi-
cation of the macular pigment density (see later). Also,
the image generated with 518-nm excitation provides
images that are minimally affected byMPmasking and
are used for our structure–function analysis (see later).
Microperimetry
For both the mesopic and the scotopic test, a
Goldmann III size (0.43 degrees diameter) was used.
A baseline infrared image was acquired and used as a
reference for tracking during the whole test. The testing
grid was centered on the preferred retinal locus (PRL)
of fixation, determined at the beginning of the test
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with a short fixation task (10 seconds) using a fixation
target of 1 degree in diameter. This meant that the
center of the grid might not coincide with the anatomic
fovea. The grid was composed of 44 testing locations
along fixed meridians (see later) plus a central testing
location and one on the optic nerve head; these two
locations were excluded from the analysis (the central
location is tested as a separate foveal location and not
tracked). The tests were preceded by a practice runwith
the “Fast” protocol to minimize learning effect.
Mesopic microperimetry was performed using a 4-
2 staircase strategy in a dark room (ambient light 0.01
lux). No adaptation was performed prior to this test.
The mesopic test has a dynamic range of 36 dB. The
scotopic testing used the same grid and PRL assess-
ment procedure but used a 2-1 staircase procedure and
two wavelengths for the stimulus, cyan (505 nm) and
red (627 nm). Prior to scotopic testing, all patients
were dark adapted for 30 minutes. The patient was sat
comfortably in the dark room, and all possible light
sources were covered. A red filter was used for the S-
MAIA screen to minimize stray light. The version of
the S-MAIA used in this study had a dynamic range
of 20 dB. We did not apply any performance-based
exclusion criteria for the microperimetric tests, requir-
ing only that the test was brought to completion.
Structure–Function Analysis
The comparison of the structure–function relation-
shipwith differentmicroperimetric tests was performed
only on eyes with macular drusen. The data from
healthy controls were used only to build a normative
reference for perimetric data. The steps for the analysis
are reported below. Both structural and functional data
were acquired on the same date. The mesopic test was
always performed before the scotopic tests (minimum
interval 40 minutes). Imaging was performed before
the microperimetric tests in 18 of 56 healthy individ-
uals and 35 of 43 people with drusen, with a minimum
interval of 20 minutes between imaging and the first
microperimetric test (mesopic).
SD-OCT Image Analysis
All scans were inspected using the Heidelberg Eye
Explorer software. The segmentations for the inner
limiting membrane and Bruch’s membrane (BM) were
manually corrected where necessary. The latter was
particularly relevant for eyes with drusen, in which the
segmentation for the BMwas often incorrect and some
degree of manual correction was needed in all volumes.
The segmentation for the RPE in healthy controls was
generally accurate, and minor errors were manually
corrected (in 10/56 volumes). In eyes with drusen, an
additional step was necessary to accurately segment
the RPE, whose elevation was used as a surrogate
of drusen thickness. This additional processing was
performed in MATLAB (MathWorks, Natick, MA,
USA). For all participants, we exported the images
from the Spectralis in RAW format (.vol). These files
contain segmentation data and the untransformed
(linear)OCT scans in single precision. For eachA-scan,
the intensity profile above the manually segmented BM
was normalized by the maximum value in the profile.
Then, the first normalized peak above a threshold of
0.4 closest to the BM was used as an initial guess
for the location of the RPE. The final segmentation
was produced by a customized version of a previously
published algorithm,27 starting from the initial guess.
The segmentation results were visually inspected and
corrected where necessary. Some degree on manual
refinement was performed in at least one section in
all volumes to obtain the best result. This segmenta-
tion was used to derive two structural maps (Fig. 2).
The first was the RPE elevation (RPE-E), obtained by
simple difference between the RPE and BM segmenta-
tion. The second was a photoreceptor reflectivity ratio
(PRR) map. This was meant to quantify the reflectivity
of the photoreceptor outer segments. For this calcula-
tion, we assumed the amount of light from the OCT
beam reaching a certain depth in the image could be
calculated by a linear sum of all the values in each
A-scan from that specific depth to the bottom of the
image (Fig. 1). A map of this value was calculated
twice starting at 6 pixels and 20 pixels above the RPE
segmentation for all the B-scans. The ratio of the two
maps provided the fraction of light back-reflected in
the path across the photoreceptor outer layers. There-
fore, a dimmer photoreceptor outer layer would make
this ratio close to 1. This calculation was performed on
the untransformed images in single precision (Fig. 1).
Alignment of Fundus Images
Fundus images from the MAIA were aligned with
the infrared SLO fundus images from the Spectralis.
The alignment needed to be performed once for the
mesopic test and once for the scotopic test, for a total of
198 image pairs. An affine or projective transformation
was used. The alignment was performed by a custom
software written in MATLAB. All alignments were
visually inspected. All failed alignments were identi-
fied and a new attempt was made with manually placed
landmarks and a projective transformation. A satisfac-
tory alignment (as evaluated by a grader, GM) could be
obtained in all the images, but manual landmarks were
necessary in 58 of 86 pairs for eyes with drusen and 67
of 112 in the healthy cohort . This alignment was used
to report the tested locations onto the structural maps
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Figure 1. Example of the calculation of the photoreceptor reflec-
tivity ratio (PRR) for a single B-scan. In short, Signal1 and Signal2 are
calculated for each A-scan as the linear sum of all the values from
the raw OCT image (middle panel) below the corresponding profile
(red for Signal1, blue for Signal2). The ratio of the two profiles is then
computed to obtain the PRR (bottom panel). Notice how the PRR
value decreases when the reflectivity of the photoreceptor layer is
reduced. The two profiles are reported on the scaled image (top
panel) for reference.
Figure 2. Example of how the tested locations were reported from
the fundus image used to track the eye during microperimetry (top-
left) onto each structural map used for this analysis. Notice how the
pattern of photoreceptor reflectivity is similar to that of drusen thick-
ness but does not completely overlap.
(OCT or FAF) and obtain colocalized measurements
within the tested areas, one for each location. FAF
images were aligned with the corresponding infrared
SLO images from the Spectralis, so that the same spatial
transformation for MAIA data could be used for both
FAF and infrared SLO images. For this second step,
the automated alignment was more often successful,
requiring manual intervention in 19 of 99 pairs. The
values were calculated as averages within the tested
areas. The GAF map was used for these calculations
to avoid the effect of MP absorption.
Compensation for Macular Pigment Absorption
Sensitivity measured with the cyan stimulus showed
a marked decrease toward the foveal center, even in
healthy patients. Since the wavelength used for this
stimulus is thought to mainly target rods,25 this behav-
ior is consistent with the decreasing rod density toward
the fovea.28 However, the same wavelength is also
partially absorbed by the MP, reducing the measured
sensitivity. Since MP density can vary across different
individuals and is known to be reduced people with
AMD,29 we developed a method to correct the sensi-
tivities for MP absorption. We calculated a map of the
MPOD as the ratio between the blue and the green
FAF signal, the latter being minimally absorbed by the
MP.30,31 TheMP absorption at 505 nm (the wavelength
of the cyan stimulus) is approximately 66% of that
at 488 nm (interpolated from the values provided by
Snodderly et al.).32 Therefore, the final compensation
for the sensitivity (in logarithmic scale) is
CdB = 10 ∗ log10 (0.66 ∗ (MPOD − 1) + 1 ) ,
whereCdB is the correction in dB that needs to be added
to the measured sensitivity. This formula assumes that
the macular pigment absorption of the GAF signal
is negligible. The result is 0 when the MPOD ratio
is equal to 1 (no absorption). This calculation conve-
niently produces a map whose average value can be
calculated for each individual tested location, as above.
All negative average values (MPOD ratio <1) were set
to zero.
Normative Reference for Microperimetry
When evaluated in normal controls, age and eccen-
tricity had very different impact on the sensitivity
measured with the mesopic and the two scotopic
tests. Therefore, to make tests comparable, we built
three normative linear models using the data from the
healthy controls. In these models, the effect of age was
significant (P < 0.05) for the mesopic and scotopic
red test but not for the scotopic cyan test (P = 0.35).
The effect of eccentricity could be modeled with a
linear relationship for the mesopic and scotopic red
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Figure 3. Normative values for the three tests. The black lines show
the fit of the normative equation (equations reported as text in each
graph). In the equations, eccentricity is in degrees and age is in
years. The sensitivities for the cyan stimulus are compensated for
macular pigment absorption. Each point represents a single tested
location.
test. Its effect was much smaller for the scotopic red
test than for the mesopic test (Fig. 3). Consistent with
the known change in rod density, the scotopic cyan
test showed a marked decrease in sensitivity toward
the fovea,28 which was retained after correction for
MP absorption. Therefore, the change for this test with
eccentricity required a more complex adjustment. A
good fit was provided by log-transforming the eccen-
tricity and fitting a quadratic polynomial. The norma-
tive equations for the three tests for completeness are
reported in Figure 3. These models used a random
effect on the intercept for the eye. However, we used
only the prediction from the fixed effects as a norma-
tive reference, which is relevant to the next step for the
analysis.
Statistical Analysis and Structure–Function Modeling
For our structure–function modeling, we used the
sensitivity loss, calculated as a difference between the
observed sensitivity and the expected values from the
normative models. This allowed us to use the exact
same structure–function modeling for all three tests
without further correction for eccentricity and age.
This was especially useful to isolate the effect of struc-
tural parameters.
The structural measurements were not corrected
for ocular magnification. This was a deliberate choice,
since all our calculations were performed in visual
degrees. Ocular magnification due to axial length only
affects the apparent lateral size of objects on the retina
but has no effect on axial measurements,33 such as
thickness. For example, the G-III stimulus used for the
microperimetric test would have the same angular size
regardless of axial length. For our structural analy-
sis, the area covered by the stimulus was then calcu-
lated based on the known angular size of the SLO
image from the Spectralis (30 × 30 degrees, 768 ×
768 pixels) and the known diameter of the stimulus
(0.43 degrees).
We used mixed-effect models with a random effect
on the intercept to account for correlations among
sensitivities measured on the same eye. The three struc-
tural predictors (RPE-E, PRR, and GAF) were log10-
transformed prior to analysis to match the scale of the
sensitivity loss. We separately tested the effect of each
parameter with univariable models and their combined
effect with a multivariable model with full interaction
terms. The R2 values were calculated using the squared
residuals from the fixed-effect predictions divided by
the variance of the sensitivity values. All calculations




R2 values and P values for the univariable analy-
sis are reported in Table 1. Both OCT predictors were
significantly related to sensitivity in the mesopic and
scotopic tests. The relationship was negative for RPE-
E and positive for PRR. GAF was also significantly
positively correlated with sensitivity in all tests (P <
0.001). Despite very significant P values, the correla-
tion was generally weak. The PRR was the strongest
predictor for all tests. Overall, the mesopic test showed
the highestR2 values, with the exception of the PRR for
the cyan test, which was the highest (Table 1). Individ-
ual equations are reported in the Appendix.
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Figure 4. Predictions from the multivariate models. The R2 for the
fixed-effect prediction is reported for each prediction. Abnormal
locations are defined as having a drusen thickness>95th percentile
of the values from the healthy cohort. Welker et al.15 reported
data from patients with iAMD but used a device with an extended
dynamic range. Pfau et al.10 used the same device as in this work but
only tested healthy individuals.
GAF was positively but very weakly correlated with
PRR (R2 = 0.003, P < 0.001) and negatively correlated
with RPE-E, with a stronger relationship (R2 = 0.02,
P< 0.001). RPE-E and PRRwere also significantly but
weakly correlated (R2 = 0.010, P = 0.015).
Multivariable Analysis
The final structure–function model used all struc-
tural predictors, including their interactions. The
relationship was generally weak (Fig. 4). As for the
univariable analysis, the strongest relationship was
obtained with the mesopic test. The scotopic red test
showed the weakest structure–function relationship. A
detailed report of the coefficient values and relative
P values of the models can be found in the Appendix.
When compared to a reducedmodel that excluded each
of the structural predictors and their interactions, all
structural parameters significantly improved the fit for
the mesopic and scotopic tests (likelihood ratio test, P
< 0.001, for all parameters except RPE-E for the red
scotopic test, for which P = 0.021). Of notice, most of
the interactionswere not significant in themodel for the
mesopic test (see Appendix). A stepwise model reduc-
tion procedure using the Akaike information crite-
rion34 yielded a much simpler model, which contained
all structural predictors and only the two-way interac-
tion betweenRPE-E and PRR.However, the three-way
interaction was significant for the scotopic tests. There-
fore, the full model was retained in all cases for fairness
of comparison.
Since most of the tested locations were not affected
by drusen, we repeated the analysis only including
the locations with abnormal RPE-E values, defined
as being larger than the 95th percentile of RPE-E
measured in healthy controls. The structure–function
relationship was improved for all tests, with an average
2.1-fold increase for the mesopic test, a 1.1-fold
increase for the scotopic red test, and a 1.8-fold increase
for the scotopic cyan test. However, the relationship
remained extremely weak for the scotopic red test. The
plots in Figure 4 report predictions from the models
along with the 95% test–retest limits of agreement
reported by Welker et al.15 and Pfau et al.10
Discussion
Our overarching goal was to identify candidate
measures that could be integrated to improve the
detection of localized progression for both individ-
ual patients and clinical trials. We evaluated different
structural and functional parameters to detect changes
to explore their relationship in people with macular
drusen, the prominent structural feature in these
patients. We compared the strength of the structure–
function relationship between microperimetric tests,
mesopic and scotopic, and OCT and FAF measure-
ments. In contrast to previous reports,20 we used a
two-wavelength scotopic test, which has the poten-
tial to target different pathways in the retina.15,25,35
Moreover, we concentrated our analysis on the predic-
tive ability of the structural parameters. This is essen-
tial to assess their usefulness for detection of disease
progression.
The strongest relationship in the multivariate analy-
sis between morphologic markers and retinal sensitiv-
ity was seen with the mesopic test. The scotopic tests
appeared to be limited by a much smaller dynamic
range. This can be clearly seen in Figure 3, where the
sensitivity values are much lower in both scotopic tests,
even in healthy individuals. One explanation for such
a difference is the use of a S-MAIA device with a
20-dB testing range. This was the same range as in
Saßmannshausen et al.20 and Pfau et al.10 A more
recent version of the device extended the testing range
to 36 dB,15,35 and this will likely improve the structure–
function relationship. However, we did not find, even
in healthy individuals, a clear saturation (ceiling effect)
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of the measurements, with only a few locations hitting
the 20-dB limits. Instead, most of the values were below
15 dB, making a floor effect a more important factor in
our results. In this context, it was notable that sensi-
tivity values in healthy individuals and patients with
drusen observed in our study were lower than those
reported byWelker et al.,15 who used a S-MAIA device
with a 36-dB dynamic range. However, the sensitiv-
ities cannot be directly compared between the two
devices, since the stimulus intensities corresponding to
the 0- to 20-dB range in our S-MAIA map to 10 to
30 dB in the new device. This also explains why a floor
effect was evident even in healthy eyes. Similar results
were reported by Pfau et al.,10 who assessed test–retest
variability in healthy eyes using a S-MAIA with our
same dynamic range.
Among the tests we used in determining structure–
function relationships, we found that the scotopic red
test performed poorly, with a small prediction range.
The scotopic cyan test performed better and just
marginally worse than the mesopic test. However, the
normative profile for the latter required more compli-
cated modeling, due to the peculiar dropoff in sensi-
tivity toward the fovea and its specific wavelength also
required an adjustment for MP absorption. This is
important, since MP concentration can vary across
individuals and is reduced in patients with AMD,29
creating differences in the intensity of light that reaches
the retina. For our analysis, we derived our correc-
tion from an independent optical analysis of blue light
absorption, which might not be available in all clinical
contexts. The strongest relationship was seen with the
mesopic test. This was likely due in part to its extended
dynamic range toward lower sensitivities. A secondary
analysis on locations with abnormal (thicker) RPE-
E values revealed that most of the locations likely
affected by drusen were correctly predicted to have
lower sensitivities (Fig. 4). These are the locations in
which progression is more likely to be observed in a
longitudinal follow-up, making this result particularly
valuable, and this is noteworthy. This was also the case
for the scotopic cyan test but not for the scotopic red
test. In general, however, the predictive power of the
structure–function models was small. This was unsur-
prising, since the sensitivity loss in patients with drusen
(not necessarily iAMD) is expected to be small15,16 and
therefore very close to the range of test–retest variabil-
ity. Indeed, the spread of residuals of the predictions
in Figure 4, at least for the mesopic test, was compat-
ible with the 95% test–retest variability range reported
by Welker et al.15 and Pfau et al.10 Hence, although
more complex modeling, such as with machine learn-
ing,36 might increase the accuracy of the prediction of
functional loss, a large improvement is unlikely. Previ-
ous work reported better structure–function relation-
ship in patients with AMD, but the results are not
always directly comparable with ours and focused on
mesopic tests. Querques et al.,37 for example, used a
clinical categorical classification of autofluorescence
patterns and included eyes with geographic atrophy.
Acton et al.38 classified the tested locations based on
the presence or absence of microperimetric defects and
studied the structural differences between these two
classes. Hence, in contrast to our work, the structural
metric was used as the independent variable in their
analysis. Work by Wu et al.16 was more similar to ours
and also reported a better predictive power of their
structure–function model for mesopic tests. However,
their model explicitly included age and eccentricity and
predicted the raw sensitivity. Given the very small sensi-
tivity loss in these patients, the parameters of age and
eccentricity are likely to be stronger predictors than
structural features. Moreover, the effect of eccentricity
was modeled with separate regression equations, one
for each location, on a limited number (five) of retinal
positions from the fovea. Such modeling relied on the
assumption that the same location in the perimetric
grid was at the same eccentricity from the fovea across
different tests. Such an assumption was not possible
in our case, since we positioned the testing grid on
the structural maps by matching the fundus pictures
from the MAIA and the Spectralis acquisitions. There-
fore, the position of the grid could vary from test to
test in relation to the anatomic fovea. Finally, if eccen-
tricity was instead included as a continuous variable,
such an approach would have required very differ-
ent structure–function models for each microperimet-
ric test, because of the large differences in the effect of
eccentricity (Fig. 3). Instead, in our analysis, age and
eccentricity were part of the normative models used as
a reference to calculate the sensitivity loss in patients
with drusen, so that the contribution of the structural
features could be isolated. Therefore, we feel that our
methodology yields results that are more reflective of
the actual effect of structural changes in patients with
drusen. Nevertheless, the modeling proposed by Wu
et al.16 would be extremely valuable if such limita-
tions could be overcome by controlling the position
of the perimetric grid. For example, OCT maps could
be used to center the perimetric grid on the anatomic
fovea across different tests and standardize its position
on the retina. This could be the objective of future
work.
In isolation, PRR was the best-performing struc-
tural predictor of sensitivity loss for all tests (Table 2),
but predictive power was low. Reflectivity of the
outer layers was also an important parameter in
previous structure–function analyses in patients with
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Table 2. R2 and P Values for the Univariable Structure–Function Correlations
R2 (P Value)
Characteristic Mesopic Scotopic, Red Scotopic, Cyan
RPE-E 0.018 (P < 0.001) 0.001 (P = 0.005) 0.013 (P < 0.001)
PRR 0.058 (P < 0.001) 0.024 (P = 0.006) 0.069 (P < 0.001)
GAF 0.022 (P < 0.001) 0.005 (P < 0.001) 2 × 10−4 (P < 0.001)
drusen.16,38,39 Compared to those reports, which used
a simple qualitative score to classify the integrity of
the outer layers, we developed a novel method that
allows for an objective and quantitative mapping of
this feature. We also performed our calculations on the
raw OCT signal rather than the transformed images,
which allowed for easy linear computations that more
precisely reflect the optical properties of the retinal
layers.40,41 One limitation of this method is that it
does not account for hyperreflective foci, which can
be indicative of more advanced damage to the outer
retina.42 The explanations for the statistically signifi-
cant effect of PRR can be multiple. Altered signal from
the outer segments can be an indicator of photore-
ceptor atrophy43,44 and therefore justify our findings.
However, optical effects might also play a role. When
the RPE is distorted by the presence of drusen, the
photoreceptors change their alignment with respect to
the optical axis of the eye. Photoreceptors are known to
interact directionally with light. This directional prefer-
ence, often referred to as the Stiles-Crawford effect,
has been shown to affect both reflectivity in OCT
imaging45,46 and retinal sensitivity.45 Therefore, it could
be a reason for the weakly concordant structural and
functional changes in patients with drusen. If this was
the only explanation, however, all the relevant infor-
mation should be captured by the RPE-E (i.e., the
changes in the geometry of the photoreceptor layer).
Instead, this parameter was a significant predictor in
both the mesopic and the scotopic cyan test even in
the multivariable analysis. Moreover, the correlation
between RPE-E and PRR, while significant, was weak.
The strongest (negative) correlation between structural
parameters was instead found for RPE-E and GAF.
The appearance of autofluorescence in drusen can be
varied and depends on the composition of the subreti-
nal material and the status of the overlying retina.43,47
In general, a reduction in FAF is thought to reflect a
poorer health of the overlying photoreceptors andRPE
cells.43,47,48 This hypothesis agrees with our results
since GAFwas a significant predictor also in the multi-
variate analysis and the only significant predictor for
the scotopic red test, with lower GAF signal corre-
sponding to lower sensitivity.
One important limitation to the application of
the proposed analysis is the time-consuming process
to segment the retinal images, especially in the
presence of drusen. However, advances in segmenta-
tion techniques49,50 might significantly contribute to
a more precise and quick quantification of relevant
features in OCT images. Moreover, the choice of the
OCT image section to measure the PRR was empiri-
cally based on preliminary calculations. A more refined
definition of its boundaries might make the calcula-
tions more robust. Other limitations were the small
sample size for the group of interest (eyes with drusen)
and the use of only cross-sectional data. Eyes in the
data set could also contain a mixture of Subretinal
Drusenoid Deposits (SDDs) and drusen. In fact, eyes
with pseudodrusen were identified only using fundus
images, regardless of their appearance on the OCT.
This was mainly due to the difficulty of reliably distin-
guishing SDDs fromdrusen on the raster scans. Finally,
our definition of healthy eyes was mainly based on
the presence of structural alterations on the OCT
scans. Other data, such as intraocular pressure or
traditional perimetry, were not available. However, no
direct statistical comparison was performed between
the healthy cohort and eyes with drusen. Any impreci-
sion in the definition of the healthy cohort has there-
fore little bearing on our results. Lens opacity could
also affect FAF imaging and microperimetric sensitiv-
ity. However, all eyes except for one with drusen had
no or very mild lens opacity as quantified by the PNS
(grades 0–1; see sample description). The only eye with
a PNS= 2 did not show a reduced sensitivity compared
to the rest of eyes with drusen. The use of systemic
drugs was also recorded, although not in detail. The
only class of drugs that could have interfered with the
perimetric test were the antidepressants, used by only
five healthy individuals and three patients with drusen.
Future work will focus on using this structure–
function framework to improve the detection of
functional progression with microperimetric tests in a
longitudinal data set. The model could be employed
as a scaling method to convert the structural measure-
ments into its functional equivalent. The progression
rate calculated on the converted structural measure-
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ments could then be used as prior knowledge in
a Bayesian framework to calculate the progression
rate of the actual functional measurements. A similar
approach has proven effective in other contexts,51
making the fitting results more robust to the intrin-
sic variability within the perimetric test. Moreover,
customized microperimetric grids could be used to
improve the detection of damage by directly sampling
over locations affected by drusen. Finally, the same
methodology could be applied to a data set enriched
with eyes with pseudodrusen and SDDs to accurately
investigate the structure–function features of this
subgroup.
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Appendix
Figure A1 shows the univariable structure–function relationship for the different structural parameters.
Table A1 reports both the full-interaction and additive-only versions of the multivariable models. For fairness
of comparison, the full-interaction models were used for all calculations, since the interactions significantly
improve the fit for the scotopic tests. However, for the mesopic test, most of the interactions were not signif-
icant. A simpler model could be achieved by stepwise selection using the Akaike information criterion.34 The
optimal model for the mesopic test is reported in Table A2. Additive-only models are reported for ease of inter-
pretation of the linear effect of each predictor on sensitivity loss. All predictors were transformed in log10 scale.
Table A3 reports the Beckman classification used in this study.
Figure A1. Univariable structure–function models. The equations for the relationship are reported inside the graphs. In the equations, all
structural predictors are assumed log10 transformed. The asterisk represents the product sign.
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Table A1. Coefficients, Reported as Estimate (Standard Error), for the Predictors in the Multivariable Models
Test Estimate (Standard Error)
Variable Mesopic P Value Scotopic, Red P Value Scotopic, Cyan P Value
Full-interaction model
Intercept –3.047 (4.208) 0.469 –13.373 (5.36) 0.013 –17.504 (4.968) <0.001
PRR –49.741 (41.579) 0.232 98.794 (52.526) 0.060 158.915 (48.742) 0.001
RPE-E –13.659 (7.261) 0.06 19.47 (8.704) 0.025 13.229 (8.055) 0.101
GAF 1.657 (2.126) 0.436 6.84 (2.687) 0.011 8.629 (2.489) 0.001
PRR × RPE-E 131.792 (71.839) 0.067 –202.157 (88.295) 0.022 –221.883 (81.945) 0.007
PRR × GAF 23.551 (20.892) 0.260 –49.594 (26.274) 0.059 –78.312 (24.372) 0.001
RPE-E × GAF 5.511 (3.706) 0.137 –10.458 (4.396) 0.017 –7.766 (4.069) 0.056
PRR × RPE-E × GAF –58.159 (36.268) 0.109 105.098 (44.242) 0.018 118.029 (41.077) 0.004
Additive-only model
Intercept –8.268 (0.996) <0.001 –3.84 (1.142) 0.001 –6.976 (1.107) <0.001
PRR 5.985 (1.362) <0.001 3.585 (1.559) 0.022 9.994 (1.529) <0.001
RPE-E –1.41 (0.277) <0.001 –0.618 (0.333) 0.063 –1.107 (0.329) 0.001
GAF 3.916 (0.462) <0.001 1.87 (0.529) <0.001 3.03 (0.512) <0.001
Table A2. Coefficients, Reported as Estimate (Standard Error), for the Predictors in the Multivariable Optimal
Model for the Mesopic Test, Selected through the Akaike Information Criterion
Test-Estimate (Standard Error)
Optimal Model Mesopic P Value
Intercept –7.317 (1.02) <0.001
PRR –3.196 (2.67) 0.231
RPE-E –2.885 (0.461) <0.001
GAF 3.835 (0.461) <0.001
PRR × RPE-E 17.304 (4.335) <0.001
Table A3. Beckman Classification Used to Grade the Color Fundus Pictures of the Participants
Numerical Code AMD Classification Stage Definition (Areas of Lesions within 2 Disc Diameters from the Foveal Center)
Beckman group 0 No obvious aging changes No drusen—no pigmentary changes*
Beckman group 1 Normal aging changes Only drusen ≤63 μm—no AMD pigmentary abnormalities*
Beckman group 2 Early AMD Medium drusen >63 μm and ≤125 μm—no AMD pigmentary abnormalities*
Beckman group 3 Intermediate AMD Large drusen >125 μm—any other AMD pigmentary changes*
Beckman group 4 Late AMD Neovascular AMD and/or any geographic atrophy
